Ruben Tommasi

7PUBLICATIONS
7CO-AUTHORS
Medical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsEnvironmental epidemiologyBiocatalysis and enzyme technologyEnvironmental biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 14, 2026
Perseverance: We Should Continue to Strive for Novel Antibiotics and Companion Diagnostics.

|Sep 16, 2021
Rational design of a new antibiotic class for drug-resistant infections.

Thomas F Durand-Reville, Alita A Miller, John P O'Donnell

|Jul 14, 2020
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases.

Thomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang

|May 08, 2020
Pharmacokinetic/Pharmacodynamic Determination and Preclinical Pharmacokinetics of the β-Lactamase Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282.

John O'Donnell, Angela Tanudra, April Chen

|Apr 08, 2020
In Vitro Characterization of ETX1317, a Broad-Spectrum β-Lactamase Inhibitor That Restores and Enhances β-Lactam Activity against Multi-Drug-Resistant Enterobacteriales, Including Carbapenem-Resistant Strains.

Alita A Miller, Adam B Shapiro, Sarah M McLeod

|Nov 30, 2018
Titrating Levels of TolC in E. coli: A Sensitive Approach to Quantifying Efflux.

Ramkumar Iyer, Samir H Moussa, Ruben Tommasi

Pageof 2

Frequent Collaborators

5 joint publications

Alita A Miller

3 joint publications

Adam B Shapiro

2 joint publications

John P O'Donnell

2 joint publications

John P Mueller